103 related articles for article (PubMed ID: 18159151)
1. [Five-year survival analysis of a cohort of hepatocellular carcinoma patients who treated at the National Cancer Center, Korea].
Park KW; Park JW; Kim TH; Choi JI; Kim SH; Park HS; Park SJ; Lee WJ; Shin HL; Kim CM
Korean J Hepatol; 2007 Dec; 13(4):530-42. PubMed ID: 18159151
[TBL] [Abstract][Full Text] [Related]
2. [Survival analysis for patients with hepatocellular carcinoma according to stage, liver function and treatment modalities].
Park KW; Park JW; Cho SH; Kim YI; Kim SH; Park HS; Lee WJ; Park SJ; Kim DY; Hong EK; Kim CM
Korean J Hepatol; 2006 Mar; 12(1):41-54. PubMed ID: 16565605
[TBL] [Abstract][Full Text] [Related]
3. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
Park KW; Park JW; Choi JI; Kim TH; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM
J Gastroenterol Hepatol; 2008 Mar; 23(3):467-73. PubMed ID: 17764529
[TBL] [Abstract][Full Text] [Related]
4. Analysis of prognostic factors and 5-year survival rate in patients with hepatocellular carcinoma: a single-center experience.
Lee SS; Shin HS; Kim HJ; Lee SJ; Lee HS; Hyun KH; Kim YH; Kwon BW; Han JH; Choi H; Kim BH; Lee JH; Kang HY; Shin HD; Song IH
Korean J Hepatol; 2012 Mar; 18(1):48-55. PubMed ID: 22511903
[TBL] [Abstract][Full Text] [Related]
5. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional conformal radiation therapy for unresectable hepatocellular carcinoma patients who had failed with or were unsuited for transcatheter arterial chemoembolization.
Liu MT; Li SH; Chu TC; Hsieh CY; Wang AY; Chang TH; Pi CP; Huang CC; Lin JP
Jpn J Clin Oncol; 2004 Sep; 34(9):532-9. PubMed ID: 15466827
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of a cohort series of patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
Kwak HW; Park JW; Nam BH; Yu A; Woo SM; Kim TH; Kim SH; Koh YH; Kim HB; Park SJ; Lee WJ; Hong EK; Kim CM
J Gastroenterol Hepatol; 2014 Apr; 29(4):820-9. PubMed ID: 24325272
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study.
Lee HS; Kim KM; Yoon JH; Lee TR; Suh KS; Lee KU; Chung JW; Park JH; Kim CY
J Clin Oncol; 2002 Nov; 20(22):4459-65. PubMed ID: 12431969
[TBL] [Abstract][Full Text] [Related]
9. Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma.
Kim JY; Sinn DH; Gwak GY; Choi GS; Saleh AM; Joh JW; Cho SK; Shin SW; Carriere KC; Ahn JH; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Clin Mol Hepatol; 2016 Jun; 22(2):250-8. PubMed ID: 27377909
[TBL] [Abstract][Full Text] [Related]
10. Treatment algorithm based on the multivariate survival analyses in patients with advanced hepatocellular carcinoma treated with trans-arterial chemoembolization.
Prajapati HJ; Kim HS
PLoS One; 2017; 12(2):e0170750. PubMed ID: 28170405
[TBL] [Abstract][Full Text] [Related]
11. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
[TBL] [Abstract][Full Text] [Related]
12. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma.
Cheng JC; Chuang VP; Cheng SH; Huang AT; Lin YM; Cheng TI; Yang PS; You DL; Jian JJ; Tsai SY; Sung JL; Horng CF
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):435-42. PubMed ID: 10802371
[TBL] [Abstract][Full Text] [Related]
13. Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection--a single-center analysis including 132 patients.
Allgaier HP; Deibert P; Olschewski M; Spamer C; Blum U; Gerok W; Blum HE
Int J Cancer; 1998 Dec; 79(6):601-5. PubMed ID: 9842968
[TBL] [Abstract][Full Text] [Related]
14. Chemoembolization related to good survival for selected patients with hepatocellular carcinoma invading segmental portal vein.
Kim JH; Shim JH; Yoon HK; Ko HK; Kim JW; Gwon DI
Liver Int; 2018 Sep; 38(9):1646-1654. PubMed ID: 29436101
[TBL] [Abstract][Full Text] [Related]
15. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort.
Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK
J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
17. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
[TBL] [Abstract][Full Text] [Related]
18. [A comparison of patients with hepatocellular carcinoma between a short-term (less than 6 months) survival group and a long-term (over 24 months) survival group after treatment with transcatheter arterial chemoembolization].
Kang IK; Kim SW; Hahn SH; Cho SC; Gham CW; Lee DH
Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):189-200. PubMed ID: 12499805
[TBL] [Abstract][Full Text] [Related]
19. Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function.
Hsu KF; Chu CH; Chan DC; Yu JC; Shih ML; Hsieh HF; Hsieh TY; Yu CY; Hsieh CB
Eur J Radiol; 2012 Mar; 81(3):466-71. PubMed ID: 21376495
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Triple-Drug Transcatheter Arterial Chemoembolization (TACE) With Single-Drug TACE Using Doxorubicin-Eluting Beads: Long-Term Survival in 313 Patients.
Gomes AS; Monteleone PA; Sayre JW; Finn RS; Sadeghi S; Tong MJ; Britten CD; Busuttil RW
AJR Am J Roentgenol; 2017 Oct; 209(4):722-732. PubMed ID: 28705059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]